Listing 1 - 10 of 13 | << page >> |
Sort by
|
Choose an application
The adrenal gland plays essential roles in the control of body homeostasis, stress and immune responses. The adrenal cortex represents up to 90% of the gland and is specialised in the production of mineralocorticoids, glucocorticoids and adrenal androgens. This production is tightly coordinated and results from a unique zonal organisation. Although our knowledge of the molecular mechanisms controlling adrenal steroidogenesis is quite extensive, for decades, the mechanisms of adrenal cortex development, cellular homeostasis and renewal have remained elusive. The advent of new high-throughput technologies and sophisticated genetic approaches has brought tremendous progress in our understanding of how the adrenal cortex achieves and maintains its particular organisation. The aim of this Frontiers in Endocrinology Topic is to provide readers with a snapshot of our current knowledge on adrenal physiology and how deregulations of these processes result in adrenal diseases. This includes but is not limited to, basic research on adrenal development, cell lineage identification, progenitor cells, tissue renewal, control of differentiation and zonation and clinical research on the identification of disease-related genes.
Adrenal cortex --- Adrenal cortex. --- Diseases. --- development --- adrenal --- Disease --- Hyperplasia --- Insufficiency --- zonation --- Physiology --- Adenoma --- Cancer
Choose an application
Malignant mesothelioma is an aggressive and fatal neoplasm of serous membranes. The pathogenesis of malignant mesothelioma is clearly linked to incorporated asbestos fibers. Owing to the late banning of asbestos use in industrial nations and the continuing mining and consumption of asbestos in many countries, the incidence of malignant mesothelioma is still rising worldwide. This book covers all the important aspects of the disease by bringing together contributions from selected experts in the fields of epidemiology, imaging, pathological diagnosis, therapy, genetics, and screening. Special emphasis is placed on the latest diagnostic techniques and current therapy standards. In addition, the mineralogy of asbestos is reviewed and clear advice is included on the analysis of tissue mineral fiber content. By providing a compact, scientifically based, and up-to-date overview of the management of malignant mesothelioma, this volume will be invaluable for all clinicians and pathologists who are engaged in the diagnosis and treatment of the disease or in related research.
Asbestos -- adverse effects. --- Asbestosis -- Toxicology. --- Mesothelioma -- Miscellanea. --- Mesothelioma. --- Silicates --- Neoplasms, Mesothelial --- Adenoma --- Silicic Acid --- Neoplasms, Glandular and Epithelial --- Minerals --- Neoplasms by Histologic Type --- Inorganic Chemicals --- Silicon Dioxide --- Neoplasms --- Silicon Compounds --- Chemicals and Drugs --- Diseases --- Asbestos --- Mesothelioma --- Medicine --- Health & Biological Sciences --- Oncology --- Mesothelial Neoplasms --- Mesothelial Neoplasm --- Neoplasm, Mesothelial --- Silicate --- Mesotheliomas --- Compounds, Silicon --- Benign Neoplasms --- Malignancy --- Neoplasia --- Neoplasm --- Neoplasms, Benign --- Cancer --- Tumors --- Benign Neoplasm --- Cancers --- Malignancies --- Neoplasias --- Neoplasm, Benign --- Tumor --- Aerosil --- Aerosil 380 --- Cristobalite --- Quso G-32 --- Quso G32 --- Tridymite --- Silica --- 380, Aerosil --- Dioxide, Silicon --- G32, Quso --- Quso G 32 --- Chemicals, Inorganic --- Histological Type of Neoplasm --- Histological Types of Neoplasms --- Neoplasms by Histological Type --- Neoplasm Histological Type --- Neoplasm Histological Types --- Neoplasms Histological Type --- Neoplasms Histological Types --- Epithelial Neoplasms --- Glandular Neoplasms --- Glandular and Epithelial Neoplasms --- Neoplasms, Epithelial --- Neoplasms, Glandular --- Neoplasms, Glandular Epithelial --- Epithelial Neoplasm --- Epithelial Neoplasm, Glandular --- Epithelial Neoplasms, Glandular --- Glandular Epithelial Neoplasm --- Glandular Epithelial Neoplasms --- Glandular Neoplasm --- Neoplasm, Epithelial --- Neoplasm, Glandular --- Neoplasm, Glandular Epithelial --- Adenoma, Basal Cell --- Adenoma, Follicular --- Adenoma, Microcystic --- Adenoma, Monomorphic --- Adenoma, Papillary --- Adenoma, Trabecular --- Adenomas --- Adenomas, Basal Cell --- Adenomas, Follicular --- Adenomas, Microcystic --- Adenomas, Monomorphic --- Adenomas, Papillary --- Adenomas, Trabecular --- Basal Cell Adenoma --- Basal Cell Adenomas --- Follicular Adenoma --- Follicular Adenomas --- Microcystic Adenoma --- Microcystic Adenomas --- Monomorphic Adenoma --- Monomorphic Adenomas --- Papillary Adenoma --- Papillary Adenomas --- Trabecular Adenoma --- Trabecular Adenomas --- Hydrated Silica Gel --- Silica Hydrate --- Silicate Hydrate --- Gel, Hydrated Silica --- Hydrate, Silica --- Hydrate, Silicate --- Silica Gel, Hydrated --- Medicine. --- Oncology. --- Medicine & Public Health. --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Diagnosis. --- Treatment. --- Mesothelium --- Oncology .
Choose an application
Mesothelioma is a global problem. Its incidence is rising in Europe, and it is a major health problem in the USA and other parts of the world, largely related to the previous use of asbestos products. Diagnosis, which rests on the pathology, is very difficult because of its diverse appearances and the potential for other diseases to mimic it. This monograph has been assembled by an international group of experts with a wealth of experience from France, UK, USA, Australia and Canada to aid in pathological diagnosis. In all these countries, the disease poses significant health problems. This book deals with clinical, radiological, epidemiological, molecular, and histopathological aspects of the disease. Tumors of the pleural, pericardial, peritoneal cavities as well as the ovary and tunica vaginalis are discussed. Differential diagnoses of serosal-based lesions are fully discussed and the use of immunohistochemical stains is explained. Plentiful illustrations give further aid to diagnosis This book is an essential reading for all diagnostic pathologists as well as general pathologists, who are sometimes required to diagnose the disease at biopsy or post mortem. It will be also invaluable read for members of the medical and legal professions who are involved with various aspects of this disease.
Medicine & Public Health. --- Pathology. --- Pneumology/Respiratory System. --- Oncology. --- Medicine. --- Pneumology. --- Médecine --- Cancérologie --- Pathologie --- Mesothelioma. --- Mesothelioma --- Adenoma --- Neoplasms, Mesothelial --- Neoplasms, Glandular and Epithelial --- Neoplasms by Histologic Type --- Neoplasms --- Diseases --- Medicine --- Health & Biological Sciences --- Oncology --- Pathology --- Mesothelium --- Tumors --- Respiratory organs --- Diseases. --- Oncology . --- Disease (Pathology) --- Medical sciences --- Medicine, Preventive --- Respiratory organs—Diseases.
Choose an application
S. González-Moreno (Ed. ) Advances in Peritoneal Surface Oncology With 45 Figures in 57 Separate Illustrations, 12 in Color and 19 Tables 123 IV Preface Santiago González-Moreno, MD, PhD Department of Surgical Oncology Centro Oncológico MD Anderson International España Calle Gómez Hemans 2 28033 Madrid Spain sgonzalez@mdanderson. es Library of Congress Control Number: 2006937141 ISSN 0080-0015 ISBN 978-3-540-30759-4 Springer Berlin Heidelberg New York This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, speci? ?cally the rights of translation, reprinting, reuse of illustrations, recitations, broadcasting, reproduction on micro? ?lm or in any other way, and storage in data banks. Duplication of this publication or parts thereof is permitted only under the provisions of the German Copyright Law of September 9, 1965, in its current version, and permission for use must always be obtained from Springer-Verlag. Violations are liable for prosecution under the German Copyright Law. Springer is part of Springer Science+Business Media http//www. springer. com Springer-Verlag Berlin Heidelberg 2007 Printed in Germany The use of general descriptive names, trademarks, etc. in this publication does not imply, even in the absence of a speci? ?c sta- ment, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. Product liability: The publishers cannot guarantee the accuracy of any information about dosage and application contained in this book. In every case the user must check such information by consulting the relevant literature.
Medicine & Public Health. --- Oncology. --- Medicine. --- Médecine --- Cancérologie --- Peritoneum -- Cancer -- Treatment. --- Peritoneum --- Carcinoma --- Drug Therapy --- Peritoneal Neoplasms --- Mesothelioma --- Neoplasms, Mesothelial --- Peritoneal Diseases --- Therapeutics --- Digestive System Neoplasms --- Adenoma --- Abdominal Neoplasms --- Neoplasms, Glandular and Epithelial --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Digestive System Diseases --- Neoplasms by Histologic Type --- Neoplasms by Site --- Diseases --- Neoplasms --- Gastroenterology --- Oncology --- Medicine --- Health & Biological Sciences --- Cancer --- Treatment --- Treatment. --- Tumors --- Chemotherapy. --- Abdomen --- Membranes (Biology)
Choose an application
This volume is the most up-to-date text available on diffuse malignant mesothelioma and includes all the newest imaging modalities, immunohistochemical features, and ever-expanding information on the molecular characteristics of the cancer. In-depth chapters contain fully referenced text as well as detailed tables and images. While the primary audiences for this book are pathologists and pathology residents, the broad examination of diffuse malignant mesothelioma, including its epidemiology, makes this book valuable to radiologists, surgeons, oncologists, and other clinical physicians and their residents as well. Written by experts in the field, Diffuse Malignant Mesothelioma is a concise yet comprehensive resource for clinicians involved in the management of one of the most widely recognized and feared cancers in the world.
Medicine & Public Health. --- Pathology. --- Oncology. --- Imaging / Radiology. --- Pneumology/Respiratory System. --- Medicine. --- Radiology, Medical. --- Pneumology. --- Médecine --- Cancérologie --- Pathologie --- Abdomen -- Cancer. --- Abdomen -- Tumors. --- Mesothelioma. --- Mesothelioma --- Immunologic Tests --- Adenoma --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Medicine --- Laboratory Techniques and Procedures --- Health Occupations --- Neoplasms, Glandular and Epithelial --- Neoplasms by Histologic Type --- Disciplines and Occupations --- Neoplasms --- Diseases --- Diagnosis --- Pathology --- Immunohistochemistry --- Health & Biological Sciences --- Mesothelium --- Tumors --- Radiology. --- Respiratory organs --- Diseases. --- Oncology . --- Clinical radiology --- Radiology, Medical --- Radiology (Medicine) --- Medical physics --- Disease (Pathology) --- Medical sciences --- Medicine, Preventive --- Respiratory organs—Diseases. --- Radiological physics --- Physics --- Radiation
Choose an application
Major technological advances in genomics have made it possible to identify critical genetic alterations in cancer, rendering oncology well along the path to “personalised cancer medicine”. Thanks to developments in genetics, several mutations and gene rearrangements have been identified in patients with endocrine cancers (e.g., thyroid and adrenocortical carcinoma). In particular, each patient can be considered as a unique, individual one, with unique genetic information. The aim of this Special Issue is to offer an overview of exciting new research in the area of endocrine tumours may set the stage for an innovative personalised management and precision medicine modalities for individualised care.New affordable individual genomic analyses, as well as the opportunity to test new compounds in primary cells may allow a personalised management of patients with endocrine malignancies. This approach may improve the prediction of clinical outcome and therapeutic effectiveness, as well as help to avoid the use of ineffective drugs. However, further efforts are needed to obtain an adjustment of clinical management in patients with endocrine cancers that would rely solely or in great part on genetic information. This Special Issue includes basic, translational, and clinical papers on personalised medicine in endocrine malignancies (i.e., thyroid and adrenal), especially focusing on diagnostic and prognostic biomarkers, as well as novel drug targets or targeted treatments, including eventual clinical trials.
Medicine --- papillary thyroid cancer --- SUV PET/CT --- BRAF V600E --- immune checkpoint inhibitors (ICIs) --- ipilimumab --- nivolumab --- prolactinoma --- Cushing’s disease --- aggressive pituitary tumor --- aggressive PitNET --- aggressive pituitary adenoma --- pituitary carcinoma --- adrenocortical cancer --- adrenal adenomas --- adrenal tumors --- p53 --- p27 --- ki-67 --- reticulin --- mitotane --- adjuvant treatment --- recurrence --- recurrence free survival --- timing --- intratumoral heterogeneity --- thyroid tumor --- BRAF --- RET/PTC rearrangements --- RAS mutation --- adrenal cortex --- carcinoma --- angiogenesis --- gene expression --- osteopontin --- hyaluronan synthase 1 --- multikinase inhibitors --- sorafenib --- lenvatinib --- differentiated thyroid cancer --- radioiodine resistance --- predictive marker --- predictors --- response to treatment --- survival --- information needs and preferences --- focus group interview --- personalized medicine --- neuroendocrine tumours --- phaeochromocytoma --- paraganglioma --- molecular clusters --- n/a --- Cushing's disease
Choose an application
Thyroid nodular disease is one of the most frequent endocrine diseases. The prevalence of thyroid focal lesions detected by imaging techniques, according to studies on different populations, ranges from 10 to 70%. In a population of women over 50 years of age, approximately half of them will have a thyroid focal lesion. However, only 18% of thyroid nodules are diagnosed as malignant. Thyroid nodular disease is the most frequently diagnosed endocrine pathology, while thyroid cancer constitues the most common endocrine malignancy and is reponsible for about 67% of deaths due to neoplasms derived from endocrine organs. The incidence of thyroid cancer has risen by about 240% in the last three decades. Due to the increased availability of imaging techniques, recently, a rise in the detectability of thyroid cancer at the stage of microcarcinoma has been observed. Diagnostic and therapeutic decisions in patients with thyroid nodules require an interdisciplinary consensus between endocrinologists and physicians of other specialities (radiologists, pathologists, surgeons, oncologists). This book focuses on current trends in novel techniques of thyroid nodule diagnostics before they are implemented in the current guidelines on the management of thyroid nodular disease.
Medicine --- thyroid nodule --- care pathway --- guidelines --- fine-needle aspiration cytology --- thyroid cancer --- COLD-PCR --- digital PCR --- BRAFV600E --- papillary thyroid cancer --- liquid biopsy --- thyroid nodules --- ultrasound --- computer-aided diagnosis --- S-Detect --- EU-TIRADS --- PTC --- thyroid --- metastasis --- Snail-1 --- primary hyperparathyroidism --- parathyroidectomy --- remedial surgery --- ectopic mediastinal localization --- persistent hypercalcemia --- ectopic thymus --- shear wave sonoelastography --- strain elastography --- metastatic lymph nodes --- shear wave elastography --- interobserver variability --- tissue aspirate parathyroid hormone assay --- recurrent renal hyperparathyroidism --- persistent renal hyperparathyroidism --- parathyroid sonography --- parathyroid scintigraphy --- thyroid surgery --- vocal cord dysfunction --- vocal cord palsy --- loss of signal --- complications --- parathyroid adenoma --- hyperparathyroidism --- PET-CT --- FEC --- FCH --- n/a --- postsurgical hypoparathyroidism --- risk-factor analysis --- time course
Choose an application
Diagnostic Imaging --- Diabetes, Gestational --- Contraception --- Infertility, Female --- Infertility, Male --- Growth Disorders --- Puberty --- Menopause --- Andropause --- Osteoporosis --- Cardiovascular Diseases --- Hypertension --- Hypoglycemia --- Adenoma --- Diabetes Mellitus, Type 1 --- Diabetes Mellitus, Type 2 --- Goiter --- Thyroid Nodule --- Hemochromatosis --- Hyperthyroidism --- Hypothyroidism --- Kidney Failure, Acute --- Amenorrhea --- Hypercalcemia --- Erectile Dysfunction --- Diagnostic imaging --- Diabetes in pregnancy --- Growth disorders --- Climacteric, Male --- Cardiovascular system --- Diabetes --- Thyroid gland --- Acute renal failure --- Impotence --- Imagerie pour le diagnostic --- Diabète chez la femme enceinte --- Stérilité féminine --- Stérilité masculine --- Troubles de la croissance --- Puberté --- Ménopause --- Ostéoporose --- Appareil cardiovasculaire --- Hypertension artérielle --- Hypoglycémie --- Adénome --- Diabète insulinodépendant --- Goitre --- Thyroïde --- Hémochromatose --- Hyperthyroïdie --- Hypothyroïdie --- Insuffisance rénale aiguë --- Aménorrhée --- Hypercalcémie --- Impuissance sexuelle --- prevention & control --- Adults --- complications --- Diseases --- Cancer --- Tumors --- Maladies --- Tumeurs --- Internship and Residency --- Endocrinology --- Diabetes Mellitus --- Endocrine Diseases --- Acute Kidney Injury. --- Diabète chez la femme enceinte --- Stérilité féminine --- Stérilité masculine --- Puberté --- Ménopause --- Ostéoporose --- Hypertension artérielle --- Hypoglycémie --- Adénome --- Diabète insulinodépendant --- Thyroïde --- Hémochromatose --- Hyperthyroïdie --- Hypothyroïdie --- Insuffisance rénale aiguë --- Aménorrhée --- Hypercalcémie --- Hypothyroidism. --- Diagnostic Imaging. --- Diabetes, Gestational. --- Contraception. --- Infertility, Female. --- Infertility, Male. --- Growth Disorders. --- Puberty. --- Menopause. --- Andropause. --- Osteoporosis. --- Hypoglycemia. --- Adenoma. --- Goiter. --- Thyroid Nodule. --- Hemochromatosis. --- Hyperthyroidism. --- Amenorrhea. --- Hypercalcemia. --- Erectile Dysfunction. --- prevention & control. --- Adults. --- complications. --- Endocrinology - textbooks --- Diabetes Mellitus - textbooks --- Endocrine Diseases - textbooks --- Endocrine system diseases --- Cardiovascular diseases --- Thyroid nodule --- Kidney failure, --- Erectile dysfunction --- Complications --- Acute
Choose an application
The initial identification of the Adenomatous polyposis coli (Apc) gene as the site of mutations in familial adenomatous polyposis (FA P) was described in 1992. A causal relationship between Apc mutations and intestinal tract tumours was confirmed three years later with the establishment of the Min mouse model. These mice are heterozygous for Apc and develop numerous intestinal tumours that mimic FA P. Subsequently, Apc has emerged as the most commonly mutated gene in colorectal cancer with reports varying between 50-80 per cent of sporadic tumours carrying such mutations. The search for how m
Adenomatous Polyposis Coli Protein. --- Adenomatous Polyposis Coli. --- Colon (Anatomy) -- Cancer. --- Colorectal Neoplasms -- Metabolism. --- Genes, APC. --- Tumor suppressor proteins. --- Colon (Anatomy) --- Tumor suppressor proteins --- Adenomatous Polyposis Coli --- Colorectal Neoplasms --- Genes, APC --- Metabolism --- Adenomatous Polyposis Coli Protein --- Intestinal Polyposis --- Intestinal Neoplasms --- Colonic Neoplasms --- Neoplastic Syndromes, Hereditary --- Colonic Diseases --- Metabolic Phenomena --- Cytoskeletal Proteins --- Genes, Tumor Suppressor --- Tumor Suppressor Proteins --- Rectal Diseases --- Adenomatous Polyps --- Proteins --- Neoplasm Proteins --- Intestinal Diseases --- Neoplasms --- Genes, Neoplasm --- Phenomena and Processes --- Gastrointestinal Neoplasms --- Genes, Recessive --- Adenoma --- Genetic Diseases, Inborn --- Gastrointestinal Diseases --- Digestive System Neoplasms --- Genes --- Diseases --- Neoplasms, Glandular and Epithelial --- Congenital, Hereditary, and Neonatal Diseases and Abnormalities --- Amino Acids, Peptides, and Proteins --- Chemicals and Drugs --- Digestive System Diseases --- Genome Components --- Neoplasms by Site --- Neoplasms by Histologic Type --- Genome --- Genetic Structures --- Genetic Phenomena --- Oncology --- Medicine --- Health & Biological Sciences --- Cancer --- Cancer. --- Antioncoproteins --- Growth suppressor proteins --- Metastasis suppressor proteins --- Colon cancer --- Colorectal cancer --- Medicine. --- Biomedicine. --- Biomedicine general. --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Antioncogenes --- Health Workforce --- Biomedicine, general.
Choose an application
This reprint includes 15 articles in the field of non-communicable Diseases, big data, and artificial intelligence, overviewing the most recent advances in the field of AI and their application potential in 3P medicine.
Medicine --- artificial intelligence --- computer-aided diagnosis --- facial phenotypes --- machine learning --- complexity theory --- dementia --- cognitive dysfunction --- neuropsychological tests --- mental status and dementia tests --- spontaneous intracerebral hemorrhage (SICH) --- 90-day function outcome --- mortality --- osteoarthritis --- venous thrombosis --- VTE risk prediction --- machine learning algorithm --- population-based cohort study --- pituitary adenoma --- craniopharyngioma --- optic chiasm --- multicenter --- treatment outcome --- liver neoplasms --- deep learning --- diabetic complication --- gene-gene interaction --- AGER --- IL6R --- multiple sclerosis --- DNA methylation --- entropy --- atherosclerosis --- plaque characterization --- physical activity --- osteoporosis --- osteoporotic fracture --- vertebral fracture --- hip fracture --- distal radius fracture --- small for gestational age --- exposure to radiation --- prediction --- coronary plaque --- major adverse cardiovascular events --- coronary artery disease --- coronary computed tomographic angiography --- acute pancreatitis --- predictor --- interventions --- type 2 diabetes mellitus (T2DM) --- prediction model --- Chinese elderly --- prediabetes --- incident diabetes --- predictive models
Listing 1 - 10 of 13 | << page >> |
Sort by
|